Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 401 articles:
HTML format
Text format



Single Articles


    January 2018
  1. SHI T, Yang X, Zhou H, Xi J, et al
    Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis.
    PLoS One. 2018;13:e0189856.
    PubMed     Text format     Abstract available


  2. BUCSICS T, Schoder M, Diermayr M, Feldner-Busztin M, et al
    Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience.
    PLoS One. 2018;13:e0189414.
    PubMed     Text format     Abstract available


  3. XU R, Jiang YF, Zhang YH, Yang X, et al
    The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson's disease: A large hospital-based study.
    PLoS One. 2018;13:e0190887.
    PubMed     Text format     Abstract available


  4. SARACINO A, Cozzi-Lepri A, Shanyinde M, Ceccherini Silberstein F, et al
    HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.
    PLoS One. 2018;13:e0190302.
    PubMed     Text format     Abstract available


  5. WANG TH, Huang PI, Hu YW, Lin KH, et al
    Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry.
    PLoS One. 2018;13:e0190098.
    PubMed     Text format     Abstract available


  6. CHEN WT, Lin GB, Lin SH, Lu CH, et al
    Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells via capsaicin receptor TRPV1.
    PLoS One. 2018;13:e0191078.
    PubMed     Text format     Abstract available


  7. HUANG Z, Huang J, Zhou T, Cao H, et al
    Prognostic value of liver stiffness measurement for the liver-related surgical outcomes of patients under hepatic resection: A meta-analysis.
    PLoS One. 2018;13:e0190512.
    PubMed     Text format     Abstract available


  8. CHOI YJ, Park SJ, Park YS, Park HS, et al
    EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.
    PLoS One. 2018;13:e0190638.
    PubMed     Text format     Abstract available


  9. MULABECIROVIC A, Mjelle AB, Gilja OH, Vesterhus M, et al
    Repeatability of shear wave elastography in liver fibrosis phantoms-Evaluation of five different systems.
    PLoS One. 2018;13:e0189671.
    PubMed     Text format     Abstract available


  10. KAWAGUCHI T, Shima T, Mizuno M, Mitsumoto Y, et al
    Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.
    PLoS One. 2018;13:e0185490.
    PubMed     Text format     Abstract available


  11. TESHIMA T, Matsumoto H, Koyama H
    Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion.
    PLoS One. 2018;13:e0191539.
    PubMed     Text format     Abstract available


  12. PAPACKOVA Z, Heczkova M, Dankova H, Sticova E, et al
    Silymarin prevents acetaminophen-induced hepatotoxicity in mice.
    PLoS One. 2018;13:e0191353.
    PubMed     Text format     Abstract available


  13. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0191358.
    PubMed     Text format     Abstract available


  14. HE X, Wu J, Holtorf AP, Rinde H, et al
    Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China.
    PLoS One. 2018;13:e0191095.
    PubMed     Text format     Abstract available


  15. GONG L, Huang YT, Wong CH, Chao WC, et al
    Culture-independent analysis of liver abscess using nanopore sequencing.
    PLoS One. 2018;13:e0190853.
    PubMed     Text format     Abstract available


  16. BENMASSAOUD A, Ghali P, Cox J, Wong P, et al
    Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection.
    PLoS One. 2018;13:e0191985.
    PubMed     Text format     Abstract available


  17. NARAN NH, Haagensen M, Crowther NJ
    Steatosis in South African women: How much and why?
    PLoS One. 2018;13:e0191388.
    PubMed     Text format     Abstract available


  18. FERRIGNO A, Di Pasqua LG, Berardo C, Siciliano V, et al
    The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.
    PLoS One. 2018;13:e0191430.
    PubMed     Text format     Abstract available


  19. YAMADA K, Mizukoshi E, Seike T, Horii R, et al
    Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0191026.
    PubMed     Text format     Abstract available


  20. LIANG DY, Huang W, Chang Q, Hou YQ, et al
    ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-kappaB dependent cFLIPL expression.
    PLoS One. 2018;13:e0191545.
    PubMed     Text format     Abstract available


  21. LE CT, Nguyen G, Park SY, Choi DH, et al
    LY2405319, an analog of fibroblast growth factor 21 ameliorates alpha-smooth muscle actin production through inhibition of the succinate-G-protein couple receptor 91 (GPR91) pathway in mice.
    PLoS One. 2018;13:e0192146.
    PubMed     Text format     Abstract available


  22. CHANG W, Lee JM, Lee DH, Yoon JH, et al
    Comparison of switching bipolar ablation with multiple cooled wet electrodes and switching monopolar ablation with separable clustered electrode in treatment of small hepatocellular carcinoma: A randomized controlled trial.
    PLoS One. 2018;13:e0192173.
    PubMed     Text format     Abstract available


  23. MAIOLI M, Basoli V, Carta P, Fabbri D, et al
    Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells.
    PLoS One. 2018;13:e0192178.
    PubMed     Text format     Abstract available


  24. RAUBER P, Lammert F, Grotemeyer K, Appenrodt B, et al
    Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study.
    PLoS One. 2018;13:e0192271.
    PubMed     Text format     Abstract available


  25. GONZALEZ-CANTERO J, Martin-Rodriguez JL, Gonzalez-Cantero A, Arrebola JP, et al
    Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI.
    PLoS One. 2018;13:e0192663.
    PubMed     Text format     Abstract available


  26. YANG C, Yang S, Feng C, Zhang C, et al
    Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study.
    PLoS One. 2018;13:e0192396.
    PubMed     Text format     Abstract available


  27. PRAKTIKNJO M, Krabbe V, Pohlmann A, Sampels M, et al
    Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma.
    PLoS One. 2018;13:e0192897.
    PubMed     Text format     Abstract available


  28. EBERHARDT C, Wurnig MC, Wirsching A, Rossi C, et al
    Prediction of small for size syndrome after extended hepatectomy: Tissue characterization by relaxometry, diffusion weighted magnetic resonance imaging and magnetization transfer.
    PLoS One. 2018;13:e0192847.
    PubMed     Text format     Abstract available


  29. PACHIKIAN BD, Druart C, Catry E, Bindels LB, et al
    Implication of trans-11,trans-13 conjugated linoleic acid in the development of hepatic steatosis.
    PLoS One. 2018;13:e0192447.
    PubMed     Text format     Abstract available


  30. YETTI H, Naito H, Yuan Y, Jia X, et al
    Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet.
    PLoS One. 2018;13:e0192863.
    PubMed     Text format     Abstract available


  31. ROMERO-IBARGUENGOITIA ME, Vadillo-Ortega F, Caballero AE, Ibarra-Gonzalez I, et al
    Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.
    PLoS One. 2018;13:e0193138.
    PubMed     Text format     Abstract available


  32. KAKOSCHKY B, Pleli T, Schmithals C, Zeuzem S, et al
    Selective targeting of tumor associated macrophages in different tumor models.
    PLoS One. 2018;13:e0193015.
    PubMed     Text format     Abstract available


  33. SZYMCZAK M, Kalicinski P, Kowalewski G, Broniszczak D, et al
    Acute liver failure in children-Is living donor liver transplantation justified?
    PLoS One. 2018;13:e0193327.
    PubMed     Text format     Abstract available


  34. LEE JE, Lee YJ, Chung SY, Cho HW, et al
    Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men.
    PLoS One. 2018;13:e0193191.
    PubMed     Text format     Abstract available


  35. CHRISTENSEN CU, Glavind E, Thomsen KL, Kim YO, et al
    Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0192728.
    PubMed     Text format     Abstract available


  36. HOF J, Joosten HJ, Havenga K, de Jong KP, et al
    Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
    PLoS One. 2018;13:e0193385.
    PubMed     Text format     Abstract available


  37. MAYR U, Karsten E, Lahmer T, Rasch S, et al
    Impact of large volume paracentesis on respiratory parameters including transpulmonary pressure and on transpulmonary thermodilution derived hemodynamics: A prospective study.
    PLoS One. 2018;13:e0193654.
    PubMed     Text format     Abstract available


  38. ZEKRI AN, El-Sisi ER, Youssef ASE, Kamel MM, et al
    MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
    PLoS One. 2018;13:e0193709.
    PubMed     Text format     Abstract available


  39. LUO L, Aubrecht J, Li D, Warner RL, et al
    Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans.
    PLoS One. 2018;13:e0193824.
    PubMed     Text format     Abstract available


  40. WATTANAVANITCHAKORN S, Rojvirat P, Chavalit T, MacDonald MJ, et al
    CCAAT-enhancer binding protein-alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
    PLoS One. 2018;13:e0194252.
    PubMed     Text format     Abstract available


  41. HEMMINGER J, Arole V, Ayoub I, Brodsky SV, et al
    Acute glomerulonephritis with large confluent IgA-dominant deposits associated with liver cirrhosis.
    PLoS One. 2018;13:e0193274.
    PubMed     Text format     Abstract available


  42. TANNUS RK, Almeida-Carvalho SR, Loureiro-Matos CA, Miziara-Gonzalez A, et al
    Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
    PLoS One. 2018;13:e0194922.
    PubMed     Text format     Abstract available


  43. SHAHEEN AA, Kaplan GG, Almishri W, Vallerand I, et al
    The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
    PLoS One. 2018;13:e0194839.
    PubMed     Text format     Abstract available


  44. BIAN S, Chen H, Wang L, Fei Y, et al
    Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.
    PLoS One. 2018;13:e0194397.
    PubMed     Text format     Abstract available


  45. LIAO CY, Chung CH, Chu P, Wei KY, et al
    Increased risk of osteoporosis in patients with primary biliary cirrhosis.
    PLoS One. 2018;13:e0194418.
    PubMed     Text format     Abstract available


  46. ALEXANDER KS, Zakai NA, Lidofsky SD, Callas PW, et al
    Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.
    PLoS One. 2018;13:e0194153.
    PubMed     Text format     Abstract available


  47. KELLER S, Aigner A, Zenouzi R, Kim AC, et al
    Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis.
    PLoS One. 2018;13:e0193929.
    PubMed     Text format     Abstract available


  48. JANSEN C, Al-Kassou B, Lehmann J, Pohlmann A, et al
    Severe abnormal Heart Rate Turbulence Onset is associated with deterioration of liver cirrhosis.
    PLoS One. 2018;13:e0195631.
    PubMed     Text format     Abstract available


  49. HONDA F, Hiramatsu A, Hyogo H, Aikata H, et al
    Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring.
    PLoS One. 2018;13:e0195028.
    PubMed     Text format     Abstract available


  50. CHENG YL, Shu JH, Hsu HC, Liang Y, et al
    High health literacy is associated with less obesity and lower Framingham risk score: Sub-study of the VGH-HEALTHCARE trial.
    PLoS One. 2018;13:e0194813.
    PubMed     Text format     Abstract available


  51. ONICIU DC, Hashiguchi T, Shibazaki Y, Bisgaier CL, et al
    Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM model of NASH.
    PLoS One. 2018;13:e0194568.
    PubMed     Text format     Abstract available


  52. PARK IK, Yu JS, Cho ES, Kim JH, et al
    Apparent diffusion coefficient of hepatocellular carcinoma on diffusion-weighted imaging: Histopathologic tumor grade versus arterial vascularity during dynamic magnetic resonance imaging.
    PLoS One. 2018;13:e0197070.
    PubMed     Text format     Abstract available


  53. YUAN LT, Chuah SK, Yang SC, Liang CM, et al
    Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis.
    PLoS One. 2018;13:e0197127.
    PubMed     Text format     Abstract available


  54. AXLEY P, Mudumbi S, Sarker S, Kuo YF, et al
    Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications.
    PLoS One. 2018;13:e0197117.
    PubMed     Text format     Abstract available


  55. MAK D, Babb de Villiers C, Chasela C, Urban MI, et al
    Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012.
    PLoS One. 2018;13:e0196057.
    PubMed     Text format     Abstract available


  56. ZHANG B, Chen M, Zhang Y, Chen W, et al
    An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma.
    PLoS One. 2018;13:e0196686.
    PubMed     Text format     Abstract available


  57. SU YB, Li TH, Huang CC, Tsai HC, et al
    Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model.
    PLoS One. 2018;13:e0194867.
    PubMed     Text format     Abstract available


  58. OKAMOTO M, Miyake T, Kitai K, Furukawa S, et al
    Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study.
    PLoS One. 2018;13:e0195147.
    PubMed     Text format     Abstract available


  59. BONNET E, Moutet ML, Baulard C, Bacq-Daian D, et al
    Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples.
    PLoS One. 2018;13:e0195471.
    PubMed     Text format     Abstract available


  60. FRICKE IB, De Souza R, Costa Ayub L, Francia G, et al
    Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    PLoS One. 2018;13:e0196892.
    PubMed     Text format     Abstract available


  61. DUTTA S, Chakraborty AK, Dey P, Kar P, et al
    Amelioration of CCl4 induced liver injury in swiss albino mice by antioxidant rich leaf extract of Croton bonplandianus Baill.
    PLoS One. 2018;13:e0196411.
    PubMed     Text format     Abstract available


  62. REITER R, Wetzel M, Hamesch K, Strnad P, et al
    Comparison of non-invasive assessment of liver fibrosis in patients with alpha1-antitrypsin deficiency using magnetic resonance elastography (MRE), acoustic radiation force impulse (ARFI) Quantification, and 2D-shear wave elastography (2D-SWE).
    PLoS One. 2018;13:e0196486.
    PubMed     Text format     Abstract available


  63. OFFOR O, Utay N, Reynoso D, Somasunderam A, et al
    Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.
    PLoS One. 2018;13:e0196395.
    PubMed     Text format     Abstract available


  64. KROHN S, Zeller K, Bohm S, Chatzinotas A, et al
    Molecular quantification and differentiation of Candida species in biological specimens of patients with liver cirrhosis.
    PLoS One. 2018;13:e0197319.
    PubMed     Text format     Abstract available


  65. TINGUELY P, Schwalbe M, Fuss T, Guensch DP, et al
    Multi-Operational Selective Computer-Assisted Targeting of hepatocellular carcinoma-Evaluation of a novel approach for navigated tumor ablation.
    PLoS One. 2018;13:e0197914.
    PubMed     Text format     Abstract available


  66. ZHAO W, Liu W, Liu H, Yi X, et al
    Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging.
    PLoS One. 2018;13:e0197488.
    PubMed     Text format     Abstract available


  67. KALMAN R, Stawarz A, Nunes D, Zhang D, et al
    Biophotonic detection of high order chromatin alterations in field carcinogenesis predicts risk of future hepatocellular carcinoma: A pilot study.
    PLoS One. 2018;13:e0197427.
    PubMed     Text format     Abstract available


  68. SETHUNATH D, Morusu S, Tuceryan M, Cummings OW, et al
    Automated assessment of steatosis in murine fatty liver.
    PLoS One. 2018;13:e0197242.
    PubMed     Text format     Abstract available


    January 2017
  69. CARVALHO AC, Leal F, Sasse AD
    Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.
    PLoS One. 2017;12:e0175409.
    PubMed     Text format     Abstract available


  70. GERTH HU, Pohlen M, Tholking G, Pavenstadt H, et al
    Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.
    PLoS One. 2017;12:e0175529.
    PubMed     Text format     Abstract available


  71. YAO L, Chen W, Song K, Han C, et al
    15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
    PLoS One. 2017;12:e0176106.
    PubMed     Text format     Abstract available


  72. LYTLE KA, Wong CP, Jump DB
    Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    PLoS One. 2017;12:e0173376.
    PubMed     Text format     Abstract available


  73. HE J, Yi B, Chen Y, Huang Q, et al
    The ET-1-mediated carbonylation and degradation of ANXA1 induce inflammatory phenotype and proliferation of pulmonary artery smooth muscle cells in HPS.
    PLoS One. 2017;12:e0175443.
    PubMed     Text format     Abstract available


  74. ALVA A, Cangalaya C, Quiliano M, Krebs C, et al
    Mathematical algorithm for the automatic recognition of intestinal parasites.
    PLoS One. 2017;12:e0175646.
    PubMed     Text format     Abstract available


  75. PEREZ P, Rodriguez-Peralvarez M, Guerrero L, Gonzalez V, et al
    Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
    PLoS One. 2017;12:e0175010.
    PubMed     Text format     Abstract available


  76. IBUSUKI R, Uto H, Oda K, Ohshige A, et al
    Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis.
    PLoS One. 2017;12:e0174913.
    PubMed     Text format     Abstract available


  77. PEREYRA D, Offensperger F, Klinglmueller F, Haegele S, et al
    Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.
    PLoS One. 2017;12:e0175359.
    PubMed     Text format     Abstract available


  78. KANG YM, Jung CH, Cho YK, Lee SE, et al
    Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.
    PLoS One. 2017;12:e0175762.
    PubMed     Text format     Abstract available


  79. YOON K, Jeong WK, Kim Y, Kim MY, et al
    2-dimensional shear wave elastography: Interobserver agreement and factors related to interobserver discrepancy.
    PLoS One. 2017;12:e0175747.
    PubMed     Text format     Abstract available


  80. ROTH JA, Widmer AF, Tschudin-Sutter S, Dangel M, et al
    The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study.
    PLoS One. 2017;12:e0175669.
    PubMed     Text format     Abstract available


  81. WANKHADE UD, Zhong Y, Kang P, Alfaro M, et al
    Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations.
    PLoS One. 2017;12:e0175675.
    PubMed     Text format     Abstract available


  82. MCPHERSON S, Wilkinson N, Tiniakos D, Wilkinson J, et al
    A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0175717.
    PubMed     Text format     Abstract available


  83. YANG SC, Hsu CN, Liang CM, Tai WC, et al
    Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.
    PLoS One. 2017;12:e0168918.
    PubMed     Text format     Abstract available


  84. MULDER P, van den Hoek AM, Kleemann R
    The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis.
    PLoS One. 2017;12:e0169740.
    PubMed     Text format     Abstract available


  85. WANG HL, Zhang H, Wu SL, Liao GC, et al
    Red blood cell count has an independent contribution to the prediction of ultrasonography-diagnosed fatty liver disease.
    PLoS One. 2017;12:e0172027.
    PubMed     Text format     Abstract available


  86. GRZELAK CA, Sigglekow ND, Tirnitz-Parker JE, Hamson EJ, et al
    Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease.
    PLoS One. 2017;12:e0171480.
    PubMed     Text format     Abstract available


  87. GIMENEZ-GARZO C, Garces JJ, Urios A, Mangas-Losada A, et al
    The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients.
    PLoS One. 2017;12:e0171211.
    PubMed     Text format     Abstract available


  88. TRAYKOVA D, Schneider B, Chojkier M, Buck M, et al
    Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients.
    PLoS One. 2017;12:e0169310.
    PubMed     Text format     Abstract available


  89. HU W, Shao X, Guo D, Hao H, et al
    Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population.
    PLoS One. 2017;12:e0170758.
    PubMed     Text format     Abstract available


  90. CROOME KP, Lee DD, Harnois D, Taner CB, et al
    Effects of the Share 35 Rule on Waitlist and Liver Transplantation Outcomes for Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170673.
    PubMed     Text format     Abstract available


  91. ZHAO J, Zhai F, Cheng J, He Q, et al
    Evaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography.
    PLoS One. 2017;12:e0170073.
    PubMed     Text format     Abstract available


  92. XU X, Su L, Gao Y, Ding Y, et al
    The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
    PLoS One. 2017;12:e0169952.
    PubMed     Text format     Abstract available


  93. WAKAMATSU T, Ogasawara S, Chiba T, Yokoyama M, et al
    Impact of Radiofrequency Ablation-Induced Glisson's Capsule-Associated Complications in Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170153.
    PubMed     Text format     Abstract available


  94. RISHI P, Arora S, Kaur UJ, Chopra K, et al
    Better Management of Alcohol Liver Disease Using a 'Microstructured Synbox' System Comprising L. plantarum and EGCG.
    PLoS One. 2017;12:e0168459.
    PubMed     Text format     Abstract available


  95. YOUNS M, Abdel Halim Hegazy W
    The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
    PLoS One. 2017;12:e0169335.
    PubMed     Text format     Abstract available


  96. KARAJAMAKI AJ, Kettunen O, Lepojarvi S, Koivurova OP, et al
    Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.
    PLoS One. 2017;12:e0173855.
    PubMed     Text format     Abstract available


  97. CANNITO S, Morello E, Bocca C, Foglia B, et al
    Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0172575.
    PubMed     Text format     Abstract available


  98. JIN F, Wan C, Li W, Yao L, et al
    Formononetin protects against acetaminophen-induced hepatotoxicity through enhanced NRF2 activity.
    PLoS One. 2017;12:e0170900.
    PubMed     Text format     Abstract available


  99. SOTHMANN T, Gauer T, Werner R
    4D dose simulation in volumetric arc therapy: Accuracy and affecting parameters.
    PLoS One. 2017;12:e0172810.
    PubMed     Text format     Abstract available


  100. HOLLENBACH M, Thonig A, Pohl S, Ripoll C, et al
    Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis.
    PLoS One. 2017;12:e0171260.
    PubMed     Text format     Abstract available


  101. SHEU MJ, Hsieh MJ, Chou YE, Wang PH, et al
    Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma.
    PLoS One. 2017;12:e0172506.
    PubMed     Text format     Abstract available


  102. BORGATTI A, Winter AL, Stuebner K, Scott R, et al
    Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
    PLoS One. 2017;12:e0172651.
    PubMed     Text format     Abstract available


  103. LI Q, Wang Y, Ma T, Lv Y, et al
    Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0171129.
    PubMed     Text format     Abstract available


  104. ZHANG BB, Yan C, Fang F, Du Y, et al
    Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis.
    PLoS One. 2017;12:e0171005.
    PubMed     Text format     Abstract available


  105. WERNLY B, Lichtenauer M, Franz M, Kabisch B, et al
    Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    PLoS One. 2017;12:e0170987.
    PubMed     Text format     Abstract available


  106. SALDANA RS, Schrem H, Barthold M, Kaltenborn A, et al
    Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.
    PLoS One. 2017;12:e0170499.
    PubMed     Text format     Abstract available


  107. YOO JE, Kim YJ, Rhee H, Kim H, et al
    Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis.
    PLoS One. 2017;12:e0170465.
    PubMed     Text format     Abstract available


  108. LEE DH, Lee JH, Jung YJ, Gim J, et al
    Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.
    PLoS One. 2017;12:e0170394.
    PubMed     Text format     Abstract available


  109. GAO W, Zhao J, Gao Z, Li H, et al
    Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and Inactivation.
    PLoS One. 2017;12:e0170350.
    PubMed     Text format     Abstract available


  110. LEE LH, Hwang JI, Cheng YC, Wu CY, et al
    Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0169655.
    PubMed     Text format     Abstract available


  111. LU M, Zessin AS, Glover W, Hsu DS, et al
    Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
    PLoS One. 2017;12:e0169439.
    PubMed     Text format     Abstract available


  112. LE MH, Devaki P, Ha NB, Jun DW, et al
    Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
    PLoS One. 2017;12:e0173499.
    PubMed     Text format     Abstract available


  113. MO HY, Liao YY, You XM, Cucchetti A, et al
    Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.
    PLoS One. 2017;12:e0174222.
    PubMed     Text format     Abstract available


  114. MA S, Yang J, Song C, Ge Z, et al
    Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
    PLoS One. 2017;12:e0173700.
    PubMed     Text format     Abstract available


  115. TROUVE P, Genin E, Ferec C
    In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.
    PLoS One. 2017;12:e0173822.
    PubMed     Text format     Abstract available


  116. ABO-HADED HM, Elkablawy MA, Al-Johani Z, Al-Ahmadi O, et al
    Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity.
    PLoS One. 2017;12:e0174295.
    PubMed     Text format     Abstract available


  117. XIE Z, Wang J, Liu M, Chen D, et al
    CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
    PLoS One. 2017;12:e0173252.
    PubMed     Text format     Abstract available


  118. BECKER S, Kinny-Koster B, Bartels M, Scholz M, et al
    Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
    PLoS One. 2017;12:e0174424.
    PubMed     Text format     Abstract available


  119. SU YW, Liu PH, Hsu CY, Lee YH, et al
    Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
    PLoS One. 2017;12:e0174333.
    PubMed     Text format     Abstract available


  120. HOLMILA R, Sklias A, Muller DC, Degli Esposti D, et al
    Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.
    PLoS One. 2017;12:e0174265.
    PubMed     Text format     Abstract available


  121. LOWDON RF, Wang T
    Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
    PLoS One. 2017;12:e0174032.
    PubMed     Text format     Abstract available


  122. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    PubMed     Text format     Abstract available


  123. GUTIERREZ-DE-JUAN V, Lopez de Davalillo S, Fernandez-Ramos D, Barbier-Torres L, et al
    A morphological method for ammonia detection in liver.
    PLoS One. 2017;12:e0173914.
    PubMed     Text format     Abstract available


  124. INZAUGARAT ME, De Matteo E, Baz P, Lucero D, et al
    New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans.
    PLoS One. 2017;12:e0172900.
    PubMed     Text format     Abstract available


  125. KATHER JN, Zollner FG, Schad LR, Melchers SM, et al
    Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0171378.
    PubMed     Text format     Abstract available


  126. LEE J, Yoon K, Ryu S, Chang Y, et al
    High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.
    PLoS One. 2017;12:e0172666.
    PubMed     Text format     Abstract available


  127. WU PY, Cheng CY, Liu CE, Lee YC, et al
    Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
    PLoS One. 2017;12:e0171596.
    PubMed     Text format     Abstract available


  128. PRAJAPATI HJ, Kim HS
    Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization.
    PLoS One. 2017;12:e0170750.
    PubMed     Text format     Abstract available


  129. TAI CS, Lin YR, Teng TH, Lin PY, et al
    Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.
    PLoS One. 2017;12:e0171269.
    PubMed     Text format     Abstract available


  130. VAN DEN BERG EH, Amini M, Schreuder TC, Dullaart RP, et al
    Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    PLoS One. 2017;12:e0171502.
    PubMed     Text format     Abstract available


  131. LACOSTE B, Raymond VA, Cassim S, Lapierre P, et al
    Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties.
    PLoS One. 2017;12:e0171215.
    PubMed     Text format     Abstract available


  132. KAJI K, Mizukoshi E, Yamashita T, Arai K, et al
    Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170291.
    PubMed     Text format     Abstract available


  133. CHENG SB, Liu HT, Chen SY, Lin PT, et al
    Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection.
    PLoS One. 2017;12:e0170016.
    PubMed     Text format     Abstract available


  134. LI C, Ni J, Liu YX, Wang H, et al
    Response of MiRNA-22-3p and MiRNA-149-5p to Folate Deficiency and the Differential Regulation of MTHFR Expression in Normal and Cancerous Human Hepatocytes.
    PLoS One. 2017;12:e0168049.
    PubMed     Text format     Abstract available


  135. YOO HJ, Hwang SY, Choi JH, Lee HJ, et al
    Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.
    PLoS One. 2017;12:e0174717.
    PubMed     Text format     Abstract available


  136. TAKAHASHI A, Kono S, Wada A, Oshima S, et al
    Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy.
    PLoS One. 2017;12:e0174169.
    PubMed     Text format     Abstract available


  137. KOMIYAMA Y, Kurosaki M, Nakanishi H, Takahashi Y, et al
    Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.
    PLoS One. 2017;12:e0174649.
    PubMed     Text format     Abstract available


  138. LEE M, Jo A, Lee S, Kim JB, et al
    3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0174271.
    PubMed     Text format     Abstract available


  139. GAO B, Zhang X, Huang Y, Yang Z, et al
    Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.
    PLoS One. 2017;12:e0174142.
    PubMed     Text format     Abstract available


  140. JIN X, Liu J, Chen YP, Xiang Z, et al
    Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis.
    PLoS One. 2017;12:e0174218.
    PubMed     Text format     Abstract available


  141. LI Y, Dong Y, Huang Z, Kuang Q, et al
    Computational identifying and characterizing circular RNAs and their associated genes in hepatocellular carcinoma.
    PLoS One. 2017;12:e0174436.
    PubMed     Text format     Abstract available


  142. STRATIGOPOULOU P, Paul A, Hoyer DP, Kykalos S, et al
    High MELD score and extended operating time predict prolonged initial ICU stay after liver transplantation and influence the outcome.
    PLoS One. 2017;12:e0174173.
    PubMed     Text format     Abstract available


  143. LEE JS, Yoo JE, Kim H, Rhee H, et al
    Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.
    PLoS One. 2017;12:e0171922.
    PubMed     Text format     Abstract available


  144. WANG Y, Stewart E, Desjardins L, Hadway J, et al
    Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.
    PLoS One. 2017;12:e0173016.
    PubMed     Text format     Abstract available


  145. DIJKSTRA H, Wolff D, van Melle JP, Bartelds B, et al
    Diminished liver microperfusion in Fontan patients: A biexponential DWI study.
    PLoS One. 2017;12:e0173149.
    PubMed     Text format     Abstract available


  146. LEDE V, Meusel A, Garten A, Popkova Y, et al
    Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor.
    PLoS One. 2017;12:e0172000.
    PubMed     Text format     Abstract available


  147. WU L, Pang Y, Qin G, Xi G, et al
    Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.
    PLoS One. 2017;12:e0171840.
    PubMed     Text format     Abstract available


  148. ZHU Z, Tran H, Mathahs MM, Moninger TO, et al
    HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
    PLoS One. 2017;12:e0166853.
    PubMed     Text format     Abstract available


  149. LEE SM, Lee JM, Kang HJ, Yang HK, et al
    Liver fibrosis staging with a new 2D-shear wave elastography using comb-push technique: Applicability, reproducibility, and diagnostic performance.
    PLoS One. 2017;12:e0177264.
    PubMed     Text format     Abstract available


  150. YANG C, Yang S, Xu W, Zhang J, et al
    Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.
    PLoS One. 2017;12:e0177249.
    PubMed     Text format     Abstract available


  151. HUANG JF, Yeh ML, Huang CF, Huang CI, et al
    Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients.
    PLoS One. 2017;12:e0174394.
    PubMed     Text format     Abstract available


  152. ZHANG S, Xiao Q, Shi Z, Yu G, et al
    Caspase polymorphisms and prognosis of hepatocellular carcinoma.
    PLoS One. 2017;12:e0176802.
    PubMed     Text format     Abstract available


  153. RUEDA-ZARATE HA, Imaz-Rosshandler I, Cardenas-Ovando RA, Castillo-Fernandez JE, et al
    A computational toxicogenomics approach identifies a list of highly hepatotoxic compounds from a large microarray database.
    PLoS One. 2017;12:e0176284.
    PubMed     Text format     Abstract available


  154. NAOUR S, Espinoza BM, Aedo JE, Zuloaga R, et al
    Transcriptomic analysis of the hepatic response to stress in the red cusk-eel (Genypterus chilensis): Insights into lipid metabolism, oxidative stress and liver steatosis.
    PLoS One. 2017;12:e0176447.
    PubMed     Text format     Abstract available


  155. CHANG W, Lee JM, Yoon JH, Lee DH, et al
    No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers.
    PLoS One. 2017;12:e0176350.
    PubMed     Text format     Abstract available


  156. ROKUSZ A, Veres D, Szucs A, Bugyik E, et al
    Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.
    PLoS One. 2017;12:e0176518.
    PubMed     Text format     Abstract available


  157. ADEJUMO AC, Alliu S, Ajayi TO, Adejumo KL, et al
    Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.
    PLoS One. 2017;12:e0176416.
    PubMed     Text format     Abstract available


  158. OLDRINI G, Huertas A, Renard-Oldrini S, Taste-George H, et al
    Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.
    PLoS One. 2017;12:e0176118.
    PubMed     Text format     Abstract available


  159. ESTIU MC, Frailuna MA, Otero C, Dericco M, et al
    Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid.
    PLoS One. 2017;12:e0176504.
    PubMed     Text format     Abstract available


  160. YEN YH, Chen JB, Cheng BC, Chen JF, et al
    Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.
    PLoS One. 2017;12:e0176027.
    PubMed     Text format     Abstract available


  161. LEE HL, Cheng HL, Liu YF, Chou MC, et al
    Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
    PLoS One. 2017;12:e0176141.
    PubMed     Text format     Abstract available


  162. YANG KL, Chang WT, Hong MY, Hung KC, et al
    Prevention of TGF-beta-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation.
    PLoS One. 2017;12:e0174008.
    PubMed     Text format     Abstract available


  163. LAHTI S, Ludwig JM, Xing M, Sun L, et al
    In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study.
    PLoS One. 2017;12:e0174539.
    PubMed     Text format     Abstract available


  164. CHAN M, Chiang CL, Lee V, Cheung S, et al
    Target localization of 3D versus 4D cone beam computed tomography in lipiodol-guided stereotactic radiotherapy of hepatocellular carcinomas.
    PLoS One. 2017;12:e0174929.
    PubMed     Text format     Abstract available


  165. PEYROUX E, Santaella N, Broussolle E, Rigard C, et al
    Social cognition in Wilson's disease: A new phenotype?
    PLoS One. 2017;12:e0173467.
    PubMed     Text format     Abstract available


  166. HERRADOR Z, Fernandez-Martinez A, Gomez-Barroso D, Leon I, et al
    Mediterranean spotted fever in Spain, 1997-2014: Epidemiological situation based on hospitalization records.
    PLoS One. 2017;12:e0174745.
    PubMed     Text format     Abstract available


  167. HE CB, Lin XJ
    Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
    PLoS One. 2017;12:e0174769.
    PubMed     Text format     Abstract available


  168. CHU YW, Lin HM, Wang JJ, Weng SF, et al
    Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study.
    PLoS One. 2017;12:e0174601.
    PubMed     Text format     Abstract available


  169. WANG YC, Chou CT, Lin CP, Chen YL, et al
    The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    PLoS One. 2017;12:e0174594.
    PubMed     Text format     Abstract available


  170. LI Y, Wang J, Tang Y, Han X, et al
    Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.
    PLoS One. 2017;12:e0174291.
    PubMed     Text format     Abstract available


  171. KRAWCZYK M, Zimmermann S, Hess G, Holz R, et al
    Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.
    PLoS One. 2017;12:e0173506.
    PubMed     Text format     Abstract available


  172. SONG YN, Dong S, Wei B, Liu P, et al
    Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data.
    PLoS One. 2017;12:e0173598.
    PubMed     Text format     Abstract available


  173. VALBUSA F, Bonapace S, Agnoletti D, Scala L, et al
    Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.
    PLoS One. 2017;12:e0173398.
    PubMed     Text format     Abstract available


  174. HAGLUND S, Vikingsson S, Almer S, Soderman J, et al
    Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism.
    PLoS One. 2017;12:e0173825.
    PubMed     Text format     Abstract available


  175. TAKAHARA I, Akazawa Y, Tabuchi M, Matsuda K, et al
    Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    PLoS One. 2017;12:e0170591.
    PubMed     Text format     Abstract available


  176. WILMAN HR, Kelly M, Garratt S, Matthews PM, et al
    Characterisation of liver fat in the UK Biobank cohort.
    PLoS One. 2017;12:e0172921.
    PubMed     Text format     Abstract available


  177. WEN YF, Yang XZ, Zeng LS, Peng HH, et al
    Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
    PLoS One. 2017;12:e0172345.
    PubMed     Text format     Abstract available


  178. XUE M, Liu Y, Lyu R, Ge N, et al
    Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats.
    PLoS One. 2017;12:e0178684.
    PubMed     Text format     Abstract available


  179. JOLY P, Vignaud H, Di Martino J, Ruiz M, et al
    ERAD defects and the HFE-H63D variant are associated with increased risk of liver damages in Alpha 1-Antitrypsin Deficiency.
    PLoS One. 2017;12:e0179369.
    PubMed     Text format     Abstract available


  180. RAO ZZ, Zhang XW, Ding YL, Yang MY, et al
    miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3.
    PLoS One. 2017;12:e0178702.
    PubMed     Text format     Abstract available


  181. SIGRUENER A, Wolfrum C, Boettcher A, Kopf T, et al
    Lipidomic and metabolic changes in the P4-type ATPase ATP10D deficient C57BL/6J wild type mice upon rescue of ATP10D function.
    PLoS One. 2017;12:e0178368.
    PubMed     Text format     Abstract available


  182. BUECHTER M, Kahraman A, Manka P, Gerken G, et al
    Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation.
    PLoS One. 2017;12:e0177401.
    PubMed     Text format     Abstract available


  183. PRIETO V, Ludwig JM, Farris AB, Nagaraju GP, et al
    Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study.
    PLoS One. 2017;12:e0177212.
    PubMed     Text format     Abstract available


  184. LAI LL, Chan WK, Sthaneshwar P, Nik Mustapha NR, et al
    Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0174982.
    PubMed     Text format     Abstract available


  185. ASTROM E, Stal P, Zenlander R, Edenvik P, et al
    Reverse lectin ELISA for detecting fucosylated forms of alpha1-acid glycoprotein associated with hepatocellular carcinoma.
    PLoS One. 2017;12:e0173897.
    PubMed     Text format     Abstract available


  186. HUH JH, Kim JY, Choi E, Kim JS, et al
    The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.
    PLoS One. 2017;12:e0180951.
    PubMed     Text format     Abstract available


  187. LIU W, Li X, Zhou B, Fang S, et al
    Differential induction of apoptosis and autophagy by pyrrolizidine alkaloid clivorine in human hepatoma Huh-7.5 cells and its toxic implication.
    PLoS One. 2017;12:e0179379.
    PubMed     Text format     Abstract available


  188. PARK SH, Won HJ, Kim SY, Shin YM, et al
    Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy.
    PLoS One. 2017;12:e0179676.
    PubMed     Text format     Abstract available


  189. GRANATA V, Fusco R, Catalano O, Avallone A, et al
    Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.
    PLoS One. 2017;12:e0179951.
    PubMed     Text format     Abstract available


  190. CHANG CC, Lee WS, Hsieh HG, Chuang CL, et al
    Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats.
    PLoS One. 2017;12:e0179809.
    PubMed     Text format     Abstract available


  191. PEREIRA ENGDS, Silvares RR, Flores EEI, Rodrigues KL, et al
    Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0179654.
    PubMed     Text format     Abstract available


  192. GAO B, Yu T, Xue D, Sun B, et al
    A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis.
    PLoS One. 2017;12:e0178760.
    PubMed     Text format     Abstract available


  193. DOLD L, Luda C, Schwarze-Zander C, Boesecke C, et al
    Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).
    PLoS One. 2017;12:e0178685.
    PubMed     Text format     Abstract available


  194. NAKADE Y, Sakamoto K, Yamauchi T, Inoue T, et al
    Conophylline inhibits non-alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0178436.
    PubMed     Text format     Abstract available


  195. CHANG YP, Chen YM, Lai CH, Lin CY, et al
    The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.
    PLoS One. 2017;12:e0178676.
    PubMed     Text format     Abstract available


  196. HAN EC, Ryoo SB, Park JW, Yi JW, et al
    Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.
    PLoS One. 2017;12:e0178920.
    PubMed     Text format     Abstract available


  197. ANDRIANTSOA M, Hoibian S, Autret A, Gilabert M, et al
    An elevated serum alkaline phosphatase level in hepatic metastases of grade 1 and 2 gastrointestinal neuroendocrine tumors is unusual and of prognostic value.
    PLoS One. 2017;12:e0177971.
    PubMed     Text format     Abstract available


  198. LO CH, Yang JF, Liu MY, Jen YM, et al
    Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.
    PLoS One. 2017;12:e0177793.
    PubMed     Text format     Abstract available


  199. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Text format     Abstract available


  200. KAFFARNIK MF, Ahmadi N, Lock JF, Wuensch T, et al
    Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study.
    PLoS One. 2017;12:e0178237.
    PubMed     Text format     Abstract available


  201. SORENSON EC, Khanin R, Bamboat ZM, Cavnar MJ, et al
    Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.
    PLoS One. 2017;12:e0176562.
    PubMed     Text format     Abstract available


  202. KREMERS RMW, Kleinegris MC, Ninivaggi M, de Laat B, et al
    Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis.
    PLoS One. 2017;12:e0177020.
    PubMed     Text format     Abstract available


  203. WANG C, Yang Y, Sun D, Jiang Y, et al
    Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis.
    PLoS One. 2017;12:e0176827.
    PubMed     Text format     Abstract available


  204. WONG MW, Chen MJ, Chen HL, Kuo YC, et al
    Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligation.
    PLoS One. 2017;12:e0182529.
    PubMed     Text format     Abstract available


  205. LI SC, Lee CH, Hung CL, Wu JC, et al
    Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study.
    PLoS One. 2017;12:e0182255.
    PubMed     Text format     Abstract available


  206. KIM G, Kim KJ, Rhee Y, Lim SK, et al
    Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0182202.
    PubMed     Text format     Abstract available


  207. HUA MC, Su HM, Yao TC, Kuo ML, et al
    Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.
    PLoS One. 2017;12:e0182277.
    PubMed     Text format     Abstract available


  208. HUNG TH, Liang CM, Hsu CN, Tai WC, et al
    Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.
    PLoS One. 2017;12:e0181858.
    PubMed     Text format     Abstract available


  209. LIU P, Xu Y, Tang Y, Du M, et al
    Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men.
    PLoS One. 2017;12:e0181497.
    PubMed     Text format     Abstract available


  210. SCHLEGEL V, Treuner-Kaueroff T, Seehofer D, Berg T, et al
    Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease.
    PLoS One. 2017;12:e0181540.
    PubMed     Text format     Abstract available


  211. GOEBEL J, Sulke M, Lazik-Palm A, Goebel T, et al
    Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.
    PLoS One. 2017;12:e0181488.
    PubMed     Text format     Abstract available


  212. KAUFMANN B, Wang B, Zhong S, Laschinger M, et al
    BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness.
    PLoS One. 2017;12:e0180225.
    PubMed     Text format     Abstract available


  213. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Text format     Abstract available


  214. RISSIN DM, Lopez-Longarela B, Pernagallo S, Ilyine H, et al
    Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury.
    PLoS One. 2017;12:e0179669.
    PubMed     Text format     Abstract available


  215. CAI G, Chen B, Li Z, Wei W, et al
    The different expressed serum proteins in rhCygb treated rat model of liver fibrosis by the optimized two-dimensional gel electrophoresis.
    PLoS One. 2017;12:e0177968.
    PubMed     Text format     Abstract available


  216. KAMMOUN HL, Allen TL, Henstridge DC, Kraakman MJ, et al
    Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0179099.
    PubMed     Text format     Abstract available


  217. MATSUMOTO K, Ichimura M, Tsuneyama K, Moritoki Y, et al
    Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis.
    PLoS One. 2017;12:e0175406.
    PubMed     Text format     Abstract available


  218. KAMIMURA K, Yokoo T, Kamimura H, Sakamaki A, et al
    Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses.
    PLoS One. 2017;12:e0178991.
    PubMed     Text format     Abstract available


  219. KIM HM, Kim YM, Huh JH, Lee ES, et al
    alpha-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
    PLoS One. 2017;12:e0179204.
    PubMed     Text format     Abstract available


  220. KLOTTER V, Gunchick C, Siemers E, Rath T, et al
    Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study.
    PLoS One. 2017;12:e0178784.
    PubMed     Text format     Abstract available


  221. SOGABE M, Okahisa T, Nakasono M, Fukuno H, et al
    The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.
    PLoS One. 2017;12:e0177925.
    PubMed     Text format     Abstract available


  222. HONG M, Jung J, Park HS, Lee SM, et al
    Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways.
    PLoS One. 2017;12:e0178514.
    PubMed     Text format     Abstract available


  223. HO SW, Yeh CB, Yang SF, Yeh HW, et al
    Pneumonia is an independent risk factor for pyogenic liver abscess: A population-based, nested, case-control study.
    PLoS One. 2017;12:e0178571.
    PubMed     Text format     Abstract available


  224. LI Z, Lin B, Lin G, Wu Y, et al
    Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
    PLoS One. 2017;12:e0178580.
    PubMed     Text format     Abstract available


  225. MASARONE M, Rosato V, Aglitti A, Bucci T, et al
    Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.
    PLoS One. 2017;12:e0178473.
    PubMed     Text format     Abstract available


  226. LI M, Chen D, Huang H, Wang J, et al
    Caveolin1 protects against diet induced hepatic lipid accumulation in mice.
    PLoS One. 2017;12:e0178748.
    PubMed     Text format     Abstract available


  227. ZHENG H, Zou AE, Saad MA, Wang XQ, et al
    Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.
    PLoS One. 2017;12:e0178547.
    PubMed     Text format     Abstract available


  228. OHNO Y, Koizumi M, Nakayama H, Watanabe T, et al
    Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma.
    PLoS One. 2017;12:e0177343.
    PubMed     Text format     Abstract available


  229. HAGA Y, Kanda T, Nakamura M, Nakamoto S, et al
    Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.
    PLoS One. 2017;12:e0174153.
    PubMed     Text format     Abstract available


  230. JIA J, Qiao Y, Pilo MG, Cigliano A, et al
    Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.
    PLoS One. 2017;12:e0184068.
    PubMed     Text format     Abstract available


  231. HOU W, Gupta S, Beauchamp MC, Yuan L, et al
    Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2.
    PLoS One. 2017;12:e0182995.
    PubMed     Text format     Abstract available


  232. MATSUSHITA N, Hassanein MT, Martinez-Clemente M, Lazaro R, et al
    Gender difference in NASH susceptibility: Roles of hepatocyte Ikkbeta and Sult1e1.
    PLoS One. 2017;12:e0181052.
    PubMed     Text format     Abstract available


  233. CRUZ-BAQUERO A, Cardenas Jaramillo LM, Gutierrez-Meza M, Jarillo-Luna RA, et al
    Different behavior of myeloperoxidase in two rodent amoebic liver abscess models.
    PLoS One. 2017;12:e0182480.
    PubMed     Text format     Abstract available


  234. RODRIGUEZ K, Srivaths PR, Tal L, Watson MN, et al
    Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    PLoS One. 2017;12:e0182134.
    PubMed     Text format     Abstract available


  235. PINTER M, Haupt L, Hucke F, Bota S, et al
    The impact of thyroid hormones on patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0181878.
    PubMed     Text format     Abstract available


  236. XIMENEZ C, Gonzalez E, Nieves M, Magana U, et al
    Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants.
    PLoS One. 2017;12:e0181962.
    PubMed     Text format     Abstract available


  237. ZHANG Y, Kim DK, Lu Y, Jung YS, et al
    Orphan nuclear receptor ERRgamma is a key regulator of human fibrinogen gene expression.
    PLoS One. 2017;12:e0182141.
    PubMed     Text format     Abstract available


  238. DUCHEIX S, Montagner A, Polizzi A, Lasserre F, et al
    Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling.
    PLoS One. 2017;12:e0181393.
    PubMed     Text format     Abstract available


  239. GASLJEVIC G, Edhemovic I, Cemazar M, Brecelj E, et al
    Histopathological findings in colorectal liver metastases after electrochemotherapy.
    PLoS One. 2017;12:e0180709.
    PubMed     Text format     Abstract available


  240. KIM J, Lee DY, Park SE, Park CY, et al
    Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation.
    PLoS One. 2017;12:e0180118.
    PubMed     Text format     Abstract available


  241. YU J, Yang X, Luo Y, Yang X, et al
    Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male rats.
    PLoS One. 2017;12:e0180218.
    PubMed     Text format     Abstract available


  242. SCHOEMAKER MH, Kleemann R, Morrison MC, Verheij J, et al
    A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
    PLoS One. 2017;12:e0180648.
    PubMed     Text format     Abstract available


  243. KONG E, Chun KA, Cho IH
    Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient.
    PLoS One. 2017;12:e0180184.
    PubMed     Text format     Abstract available


  244. HO SY, Liu PH, Hsu CY, Hsia CY, et al
    Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    PLoS One. 2017;12:e0180408.
    PubMed     Text format     Abstract available


  245. YEN CH, Wang KT, Lee PY, Liu CC, et al
    Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians.
    PLoS One. 2017;12:e0179898.
    PubMed     Text format     Abstract available


  246. PRESTIGIACOMO V, Weston A, Messner S, Lampart F, et al
    Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis.
    PLoS One. 2017;12:e0179995.
    PubMed     Text format     Abstract available


  247. KANAMORI H, Nakade Y, Yamauchi T, Sakamoto K, et al
    Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
    PLoS One. 2017;12:e0180475.
    PubMed     Text format     Abstract available


  248. BAE JS, Kim JH, Yu MH, Lee DH, et al
    Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).
    PLoS One. 2017;12:e0178495.
    PubMed     Text format     Abstract available


  249. ZENG T, Wang D, Chen J, Tian Y, et al
    LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0177843.
    PubMed     Text format     Abstract available


  250. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    PubMed     Text format     Abstract available


  251. CHAN SL, Chua APG, Aminkeng F, Chee CBE, et al
    Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.
    PLoS One. 2017;12:e0186200.
    PubMed     Text format     Abstract available


  252. DING L, Wo L, Du Z, Tang L, et al
    Danshen protects against early-stage alcoholic liver disease in mice via inducing PPARalpha activation and subsequent 4-HNE degradation.
    PLoS One. 2017;12:e0186357.
    PubMed     Text format     Abstract available


  253. CICALESE L, Curcuru G, Montalbano M, Shirafkan A, et al
    Hazardous air pollutants and primary liver cancer in Texas.
    PLoS One. 2017;12:e0185610.
    PubMed     Text format     Abstract available


  254. THEIN HH, Qiao Y, Zaheen A, Jembere N, et al
    Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.
    PLoS One. 2017;12:e0185198.
    PubMed     Text format     Abstract available


  255. KHAN MAH, Ullah R, Rehman A, Rehman L, et al
    Immunolocalization and immunodetection of the excretory/secretory (ES) antigens of Fasciola gigantica.
    PLoS One. 2017;12:e0185870.
    PubMed     Text format     Abstract available


  256. YEH ML, Huang CI, Huang CF, Hsieh MY, et al
    The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0184878.
    PubMed     Text format     Abstract available


  257. AREVALO-HERRERA M, Rengifo L, Lopez-Perez M, Arce-Plata MI, et al
    Complicated malaria in children and adults from three settings of the Colombian Pacific Coast: A prospective study.
    PLoS One. 2017;12:e0185435.
    PubMed     Text format     Abstract available


  258. CHEN CT, Liu CY, Yu YB, Liu CJ, et al
    Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
    PLoS One. 2017;12:e0185210.
    PubMed     Text format     Abstract available


  259. KATSANOS K, Kitrou P, Spiliopoulos S, Maroulis I, et al
    Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0184597.
    PubMed     Text format     Abstract available


  260. LAMBERT A, Jarlier M, Gourgou Bourgade S, Conroy T, et al
    Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
    PLoS One. 2017;12:e0183288.
    PubMed     Text format     Abstract available


  261. PUENGEL T, Krenkel O, Kohlhepp M, Lefebvre E, et al
    Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury.
    PLoS One. 2017;12:e0184694.
    PubMed     Text format     Abstract available


  262. GUO H, Wu T, Lu Q, Dong J, et al
    Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults.
    PLoS One. 2017;12:e0184160.
    PubMed     Text format     Abstract available


  263. WAN X, Liu Y, Zhao Y, Sun X, et al
    Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1alpha-dependent and -independent mechanism.
    PLoS One. 2017;12:e0184213.
    PubMed     Text format     Abstract available


  264. LIU H, Zhang C, Fan X, Duan Y, et al
    Robust phase-retrieval-based X-ray tomography for morphological assessment of early hepatic echinococcosis infection in rats.
    PLoS One. 2017;12:e0183396.
    PubMed     Text format     Abstract available


  265. NIER A, Engstler AJ, Maier IB, Bergheim I, et al
    Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.
    PLoS One. 2017;12:e0183282.
    PubMed     Text format     Abstract available


  266. TSUDA T, Kaibori M, Hishikawa H, Nakatake R, et al
    Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosome has antineoplastic effects for hepatocellular carcinoma.
    PLoS One. 2017;12:e0183527.
    PubMed     Text format     Abstract available


  267. LEE JY, Shin DW, Oh JW, Kim W, et al
    Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women.
    PLoS One. 2017;12:e0182708.
    PubMed     Text format     Abstract available


  268. ALSHAREEDA AT, Sakaguchi K, Abumaree M, Mohd Zin NK, et al
    The potential of cell sheet technique on the development of hepatocellular carcinoma in rat models.
    PLoS One. 2017;12:e0184004.
    PubMed     Text format     Abstract available


  269. KURUVILLA SP, Tiruchinapally G, Crouch AC, ElSayed MEH, et al
    Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.
    PLoS One. 2017;12:e0181944.
    PubMed     Text format     Abstract available


  270. KULKARNI S, Dolezal JM, Wang H, Jackson L, et al
    Ribosomopathy-like properties of murine and human cancers.
    PLoS One. 2017;12:e0182705.
    PubMed     Text format     Abstract available


  271. WANG L, Feng Y, Ma X, Wang G, et al
    Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.
    PLoS One. 2017;12:e0182969.
    PubMed     Text format     Abstract available


  272. DING S, Jiang J, Zhang G, Bu Y, et al
    Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats.
    PLoS One. 2017;12:e0183541.
    PubMed     Text format     Abstract available


  273. MA Z, Zhang Y, Li Q, Xu M, et al
    Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1alpha expression and mitochondrial ROS production.
    PLoS One. 2017;12:e0183426.
    PubMed     Text format     Abstract available


  274. DONAIRES FS, Scatena NF, Alves-Paiva RM, Podlevsky JD, et al
    Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0183287.
    PubMed     Text format     Abstract available


  275. JUN BG, Park WY, Park EJ, Jang JY, et al
    A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis.
    PLoS One. 2017;12:e0182784.
    PubMed     Text format     Abstract available


  276. LI J, Ghazwani M, Liu K, Huang Y, et al
    Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism.
    PLoS One. 2017;12:e0182679.
    PubMed     Text format     Abstract available


  277. JIAO Y, Ding L, Chu M, Wang T, et al
    Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro.
    PLoS One. 2017;12:e0182781.
    PubMed     Text format     Abstract available


  278. CHOI YR, Kim JH, Park SJ, Hur BY, et al
    Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images.
    PLoS One. 2017;12:e0182596.
    PubMed     Text format     Abstract available


  279. GARCIA-GARCIA R, Cruz-Gomez AJ, Mangas-Losada A, Urios A, et al
    Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy.
    PLoS One. 2017;12:e0186463.
    PubMed     Text format     Abstract available


  280. BHAT M, Tazari M, Sebastiani G
    Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis.
    PLoS One. 2017;12:e0185192.
    PubMed     Text format     Abstract available


  281. DONG J, Zhai B, Sun W, Hu F, et al
    Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0185088.
    PubMed     Text format     Abstract available


  282. TUDORANCEA I, Porumb V, Trandabat A, Neaga D, et al
    New experimental model for single liver lobe hyperthermia in small animals using non-directional microwaves.
    PLoS One. 2017;12:e0184810.
    PubMed     Text format     Abstract available


  283. LUNDGREN H, Martinsson K, Cederbrant K, Jirholt J, et al
    HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity.
    PLoS One. 2017;12:e0184744.
    PubMed     Text format     Abstract available


  284. WEISS TS, Lupke M, Ibrahim S, Buechler C, et al
    Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    PLoS One. 2017;12:e0184282.
    PubMed     Text format     Abstract available


  285. KIM AY, Frantz S, Krishnan P, DeMulder D, et al
    Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System(R) for the treatment of hepatocellular carcinoma.
    PLoS One. 2017;12:e0183861.
    PubMed     Text format     Abstract available


  286. RATNASARI N, Nurdjanah S, Sadewa AH, Hakimi M, et al
    Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population.
    PLoS One. 2017;12:e0183503.
    PubMed     Text format     Abstract available


  287. MARTINELLI I, Ponziani FR, Maino A, Bhoori S, et al
    Thrombosis after liver transplantation for hepatocellular carcinoma.
    PLoS One. 2017;12:e0186699.
    PubMed     Text format     Abstract available


  288. FRIEDRICH-RUST M, Schoelzel F, Maier S, Seeger F, et al
    Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study.
    PLoS One. 2017;12:e0186720.
    PubMed     Text format     Abstract available


  289. HUBER W, Gruber A, Eckmann M, Elkmann F, et al
    Comparison of pulmonary vascular permeability index PVPI and global ejection fraction GEF derived from jugular and femoral indicator injection using the PiCCO-2 device: A prospective observational study.
    PLoS One. 2017;12:e0178372.
    PubMed     Text format     Abstract available


  290. ALCALA M, Calderon-Dominguez M, Serra D, Herrero L, et al
    Short-term vitamin E treatment impairs reactive oxygen species signaling required for adipose tissue expansion, resulting in fatty liver and insulin resistance in obese mice.
    PLoS One. 2017;12:e0186579.
    PubMed     Text format     Abstract available


  291. MANCINI M, Salomone Megna A, Ragucci M, De Luca M, et al
    Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease.
    PLoS One. 2017;12:e0185391.
    PubMed     Text format     Abstract available


  292. LAURIDSEN MM, Mikkelsen S, Svensson T, Holm J, et al
    The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.
    PLoS One. 2017;12:e0185412.
    PubMed     Text format     Abstract available


  293. CHANG JY, Kim SE, Kim TH, Woo SY, et al
    Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients.
    PLoS One. 2017;12:e0186120.
    PubMed     Text format     Abstract available


  294. MANTOVANI A, Rigolon R, Pichiri I, Bonapace S, et al
    Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.
    PLoS One. 2017;12:e0185459.
    PubMed     Text format     Abstract available


  295. LIU D, Hu Y, Guo Y, Zhu Z, et al
    Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2.
    PLoS One. 2017;12:e0184578.
    PubMed     Text format     Abstract available


  296. MORUZZI S, Guarini P, Udali S, Ruzzenente A, et al
    One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.
    PLoS One. 2017;12:e0185792.
    PubMed     Text format     Abstract available


  297. DAI D, Wen F, Zhou S, Su Z, et al
    Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children.
    PLoS One. 2017;12:e0185396.
    PubMed     Text format     Abstract available


  298. SULTAN M, Ben-Ari Z, Masoud R, Pappo O, et al
    Interleukin-1alpha and Interleukin-1beta play a central role in the pathogenesis of fulminant hepatic failure in mice.
    PLoS One. 2017;12:e0184084.
    PubMed     Text format     Abstract available


  299. MAO L, Wang Y, Wang D, Han G, et al
    TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    PLoS One. 2017;12:e0183880.
    PubMed     Text format     Abstract available


  300. YE Y, Li Z, Feng Q, Chen Z, et al
    Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3.
    PLoS One. 2017;12:e0180896.
    PubMed     Text format     Abstract available


  301. YOKOTA T, Omachi K, Suico MA, Kojima H, et al
    Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.
    PLoS One. 2017;12:e0183959.
    PubMed     Text format     Abstract available


  302. PIERCE AA, Duwaerts CC, Siao K, Mattis AN, et al
    CD18 deficiency improves liver injury in the MCD model of steatohepatitis.
    PLoS One. 2017;12:e0183912.
    PubMed     Text format     Abstract available


  303. LEI Y, Wang S, Ren B, Wang J, et al
    CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy.
    PLoS One. 2017;12:e0183680.
    PubMed     Text format     Abstract available


  304. MUKHERJEE PS, Vishnubhatla S, Amarapurkar DN, Das K, et al
    Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.
    PLoS One. 2017;12:e0187033.
    PubMed     Text format     Abstract available


  305. VAN DEN BOSSCHE L, Schoonenberg VAC, Burgener IA, Penning LC, et al
    Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts.
    PLoS One. 2017;12:e0186491.
    PubMed     Text format     Abstract available


  306. KIM D, Kim W, Kwak MS, Chung GE, et al
    Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.
    PLoS One. 2017;12:e0186702.
    PubMed     Text format     Abstract available


  307. KIM JH, Kwon HY, Ryu DH, Nam MH, et al
    Inhibition of CUG-binding protein 1 and activation of caspases are critically involved in piperazine derivative BK10007S induced apoptosis in hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0186490.
    PubMed     Text format     Abstract available


  308. COEBERGH VAN DEN BRAAK RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, et al
    High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
    PLoS One. 2017;12:e0185607.
    PubMed     Text format     Abstract available


  309. KIM S, Chang Y, Sung E, Kim CH, et al
    Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study.
    PLoS One. 2017;12:e0184506.
    PubMed     Text format     Abstract available


  310. KIM G, Kang SH, Kim MY, Baik SK, et al
    Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0186990.
    PubMed     Text format     Abstract available


  311. AUGUET T, Aragones G, Berlanga A, Martinez S, et al
    Hepcidin in morbidly obese women with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0187065.
    PubMed     Text format     Abstract available


  312. LI S, Takahara T, Fujino M, Fukuhara Y, et al
    Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice.
    PLoS One. 2017;12:e0187810.
    PubMed     Text format     Abstract available


  313. RICHTIG G, Aigelsreiter A, Schwarzenbacher D, Ress AL, et al
    SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
    PLoS One. 2017;12:e0187814.
    PubMed     Text format     Abstract available


  314. QIU J, Zhou Z, Wang J, Wang Y, et al
    Associations between fatty liver index and asymptomatic intracranial vertebrobasilar stenosis in Chinese population.
    PLoS One. 2017;12:e0187502.
    PubMed     Text format     Abstract available


  315. LEE Y, Kwon DJ, Kim YH, Ra M, et al
    HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice.
    PLoS One. 2017;12:e0185134.
    PubMed     Text format     Abstract available


  316. LEE HW, Kim KJ, Jung KS, Chon YE, et al
    The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter.
    PLoS One. 2017;12:e0187066.
    PubMed     Text format     Abstract available


  317. XU Y, Li N, Lu M, Dixon E, et al
    The effects of patient cost sharing on inpatient utilization, cost, and outcome.
    PLoS One. 2017;12:e0187096.
    PubMed     Text format     Abstract available


  318. KARTOUN U, Corey KE, Simon TG, Zheng H, et al
    The MELD-Plus: A generalizable prediction risk score in cirrhosis.
    PLoS One. 2017;12:e0186301.
    PubMed     Text format     Abstract available


  319. MARTINEZ-SERNANDEZ V, Perteguer MJ, Mezo M, Gonzalez-Warleta M, et al
    Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins.
    PLoS One. 2017;12:e0188520.
    PubMed     Text format     Abstract available


  320. PETTA S, Ciresi A, Bianco J, Geraci V, et al
    Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.
    PLoS One. 2017;12:e0186136.
    PubMed     Text format     Abstract available


  321. HSU CY, Liu PH, Ho SY, Huang YH, et al
    Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.
    PLoS One. 2017;12:e0188031.
    PubMed     Text format     Abstract available


  322. YATES KP, Deppe R, Comerford M, Masuoka H, et al
    Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease.
    PLoS One. 2017;12:e0185813.
    PubMed     Text format     Abstract available


  323. LEE MS, Bae JM, Joo SK, Woo H, et al
    Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease.
    PLoS One. 2017;12:e0188321.
    PubMed     Text format     Abstract available


  324. PAN JH, Lim Y, Kim JH, Heo W, et al
    Root bark of Ulmus davidiana var. japonica restrains acute alcohol-induced hepatic steatosis onset in mice by inhibiting ROS accumulation.
    PLoS One. 2017;12:e0188381.
    PubMed     Text format     Abstract available


  325. PINHEIRO D, Leiros L, Dau JBT, Stumbo AC, et al
    Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice.
    PLoS One. 2017;12:e0187970.
    PubMed     Text format     Abstract available


  326. MORELL CM, Fiorotto R, Meroni M, Raizner A, et al
    Notch signaling and progenitor/ductular reaction in steatohepatitis.
    PLoS One. 2017;12:e0187384.
    PubMed     Text format     Abstract available


  327. WOO HY, Han SY, Heo J, Kim DU, et al
    Role of endoscopic biliary drainage in advanced hepatocellular carcinoma with jaundice.
    PLoS One. 2017;12:e0187469.
    PubMed     Text format     Abstract available


  328. TAN Y, Zhang W, Jiang L, Yang J, et al
    Efficacy and safety of anatomic resection versus nonanatomic resection in patients with hepatocellular carcinoma: A systemic review and meta-analysis.
    PLoS One. 2017;12:e0186930.
    PubMed     Text format     Abstract available


  329. ALAZAWI W, Bernabe E, Tai D, Janicki T, et al
    Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0185902.
    PubMed     Text format     Abstract available


  330. BACIU C, Pasini E, Angeli M, Schwenger K, et al
    Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0189223.
    PubMed     Text format     Abstract available


  331. FIGORILLI F, Putignano A, Roux O, Houssel-Debry P, et al
    Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility.
    PLoS One. 2017;12:e0188151.
    PubMed     Text format     Abstract available


  332. ROGAL SS, Udawatta V, Akpan I, Moghe A, et al
    Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study.
    PLoS One. 2017;12:e0187176.
    PubMed     Text format     Abstract available


  333. YANG A, Guo Z, Ren Q, Wu L, et al
    Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study.
    PLoS One. 2017;12:e0188190.
    PubMed     Text format     Abstract available


  334. FEIG JL, Mediero A, Corciulo C, Liu H, et al
    The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin.
    PLoS One. 2017;12:e0188135.
    PubMed     Text format     Abstract available


  335. YOO W, Gjuka D, Stevenson HL, Song X, et al
    Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.
    PLoS One. 2017;12:e0189965.
    PubMed     Text format     Abstract available


  336. CEDO L, Santos D, Roglans N, Julve J, et al
    Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.
    PLoS One. 2017;12:e0189834.
    PubMed     Text format     Abstract available


  337. KO Y, Kim J, Park JK, Kim H, et al
    Limited detection of small (</= 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection.
    PLoS One. 2017;12:e0189797.
    PubMed     Text format     Abstract available


  338. ZHENG XY, Zhao X, Yang YF, Jiang HJ, et al
    Antioxidant, antiapoptotic and amino acid balance regulating activities of 1,7-dihydroxy-3,4,8-trimethoxyxanthone against dimethylnitrosamine-induced liver fibrosis.
    PLoS One. 2017;12:e0189344.
    PubMed     Text format     Abstract available


  339. HUANG YK, Yen CL, Shiu SI, Lee SW, et al
    Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.
    PLoS One. 2017;12:e0188999.
    PubMed     Text format     Abstract available


  340. RENAULT V, Tost J, Pichon F, Wang-Renault SF, et al
    aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations.
    PLoS One. 2017;12:e0189334.
    PubMed     Text format     Abstract available


  341. JEFFERY HC, McDowell P, Lutz P, Wawman RE, et al
    Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score.
    PLoS One. 2017;12:e0188649.
    PubMed     Text format     Abstract available


  342. SANDAHL TD, Stoy SH, Laursen TL, Rodgaard-Hansen S, et al
    The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.
    PLoS One. 2017;12:e0189345.
    PubMed     Text format     Abstract available


  343. PARK J, Masaki T, Mezaki Y, Yokoyama H, et al
    Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy.
    PLoS One. 2017;12:e0189346.
    PubMed     Text format     Abstract available


  344. PETA V, Tse C, Perazzo H, Munteanu M, et al
    Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.
    PLoS One. 2017;12:e0189436.
    PubMed     Text format     Abstract available


    January 2016
  345. SUN MY, Zhang L, Shi SL, Lin JN, et al
    Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.
    PLoS One. 2016;11:e0154337.
    PubMed     Text format     Abstract available


  346. MOUZAKI M, Wang AY, Bandsma R, Comelli EM, et al
    Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0151829.
    PubMed     Text format     Abstract available


  347. PAN C, Wang X, Shi K, Zheng Y, et al
    MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism.
    PLoS One. 2016;11:e0152090.
    PubMed     Text format     Abstract available


  348. ARAGONES G, Auguet T, Berlanga A, Guiu-Jurado E, et al
    Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0154601.
    PubMed     Text format     Abstract available


  349. CHIBA T, Suzuki S, Sato Y, Itoh T, et al
    Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
    PLoS One. 2016;11:e0164191.
    PubMed     Text format     Abstract available


  350. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis.
    PLoS One. 2016;11:e0164224.
    PubMed     Text format     Abstract available


  351. LIU TL, Barritt Iv AS, Weinberger M, Paul JE, et al
    Who Treats Patients with Diabetes and Compensated Cirrhosis.
    PLoS One. 2016;11:e0165574.
    PubMed     Text format     Abstract available


  352. BOUTTELL J, Lewsey J, Geue C, Antony G, et al
    The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011.
    PLoS One. 2016;11:e0162980.
    PubMed     Text format     Abstract available


  353. AMARAL KB, Silva TP, Malta KK, Carmo LA, et al
    Natural Schistosoma mansoni Infection in the Wild Reservoir Nectomys squamipes Leads to Excessive Lipid Droplet Accumulation in Hepatocytes in the Absence of Liver Functional Impairment.
    PLoS One. 2016;11:e0166979.
    PubMed     Text format     Abstract available


  354. ZHENG S, Zhang P, Chen Y, Zheng S, et al
    Inhibition of Notch Signaling Attenuates Schistosomiasis Hepatic Fibrosis via Blocking Macrophage M2 Polarization.
    PLoS One. 2016;11:e0166808.
    PubMed     Text format     Abstract available


  355. HE XX, Wu XL, Chen RP, Chen C, et al
    Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0162368.
    PubMed     Text format     Abstract available


  356. CHENG CW, Liu FC, Lin JR, Tsai YF, et al
    The Impact of Hospital/Surgeon Volume on Acute Renal Failure and Mortality in Liver Transplantation: A Nationwide Cohort Study.
    PLoS One. 2016;11:e0162992.
    PubMed     Text format     Abstract available


  357. NOVO-VELEIRO I, Cieza-Borrella C, Pastor I, Chamorro AJ, et al
    A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men.
    PLoS One. 2016;11:e0168685.
    PubMed     Text format     Abstract available


  358. TUTTOLOMONDO A, Di Raimondo D, Bellia C, Clemente G, et al
    Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.
    PLoS One. 2016;11:e0165443.
    PubMed     Text format     Abstract available


  359. LECUBE A, Valladares S, Lopez-Cano C, Gutierrez L, et al
    The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori.
    PLoS One. 2016;11:e0166741.
    PubMed     Text format     Abstract available


  360. FAN WC, Liu CW, Ou SM, Huang CC, et al
    TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients.
    PLoS One. 2016;11:e0166458.
    PubMed     Text format     Abstract available


  361. FJELD K, Beer S, Johnstone M, Zimmer C, et al
    Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis.
    PLoS One. 2016;11:e0165567.
    PubMed     Text format     Abstract available


  362. LEDE V, Franke C, Meusel A, Teupser D, et al
    Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor.
    PLoS One. 2016;11:e0167888.
    PubMed     Text format     Abstract available


  363. LANKARANI KB, Malek-Hosseini SA, Nikeghbalian S, Dehghani M, et al
    Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, Iran.
    PLoS One. 2016;11:e0167890.
    PubMed     Text format     Abstract available


  364. IGUCHI T, Nambara S, Masuda T, Komatsu H, et al
    miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis.
    PLoS One. 2016;11:e0165912.
    PubMed     Text format     Abstract available


  365. GONZALEZ-PAREDES FJ, Hernandez Mesa G, Morales Arraez D, Marcelino Reyes R, et al
    Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0156650.
    PubMed     Text format     Abstract available


  366. SCHUSTER C, Akslen LA, Straume O
    Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
    PLoS One. 2016;11:e0155242.
    PubMed     Text format     Abstract available


  367. KIM JC, Ha YJ, Tak KH, Roh SA, et al
    Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.
    PLoS One. 2016;11:e0155160.
    PubMed     Text format     Abstract available


  368. SHANAKI M, Fadaei R, Moradi N, Emamgholipour S, et al
    The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients.
    PLoS One. 2016;11:e0168082.
    PubMed     Text format     Abstract available


  369. ZHOU Z, Song K, Qiu J, Wang Y, et al
    Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males.
    PLoS One. 2016;11:e0166072.
    PubMed     Text format     Abstract available


  370. WU S, Wang YJ, Tang X, Wang Y, et al
    Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity.
    PLoS One. 2016;11:e0157478.
    PubMed     Text format     Abstract available


  371. VESPASIANI-GENTILUCCI U, Gallo P, Piemonte F, Riva E, et al
    Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology.
    PLoS One. 2016;11:e0156113.
    PubMed     Text format     Abstract available


  372. GADALEAN F, Lighezan D, Stoian D, Schiller O, et al
    The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy - A Romanian Multicenter Survey.
    PLoS One. 2016;11:e0155271.
    PubMed     Text format     Abstract available


  373. FIX OK, Liou I, Karvellas CJ, Ganger DR, et al
    Development and Pilot of a Checklist for Management of Acute Liver Failure in the Intensive Care Unit.
    PLoS One. 2016;11:e0155500.
    PubMed     Text format     Abstract available


  374. TISCHENDORF M, Miesbach W, Chattah U, Chattah Z, et al
    Differential Kinetics of Coagulation Factors and Natural Anticoagulants in Patients with Liver Cirrhosis: Potential Clinical Implications.
    PLoS One. 2016;11:e0155337.
    PubMed     Text format     Abstract available


  375. APRELIKOVA O, Tomlinson CC, Hoenerhoff M, Hixon JA, et al
    Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
    PLoS One. 2016;11:e0155262.
    PubMed     Text format     Abstract available


  376. OKAMOTO K, Koda M, Okamoto T, Onoyama T, et al
    A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
    PLoS One. 2016;11:e0154676.
    PubMed     Text format     Abstract available


  377. JEURISSEN ML, Walenbergh SM, Houben T, Hendrikx T, et al
    Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice.
    PLoS One. 2016;11:e0167199.
    PubMed     Text format     Abstract available


  378. DELEURAN T, Vilstrup H, Overgaard S, Jepsen P, et al
    No Increased Risk for Primary Osteoarthritis in Liver Cirrhosis - A Danish Nationwide Cohort Study.
    PLoS One. 2016;11:e0167134.
    PubMed     Text format     Abstract available


  379. PARK SD, Moon J, Kwon SW, Suh YJ, et al
    Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results from INTERSTELLAR Registry.
    PLoS One. 2016;11:e0159416.
    PubMed     Text format     Abstract available


  380. MARIN V, Rosso N, Dal Ben M, Raseni A, et al
    An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
    PLoS One. 2016;11:e0158817.
    PubMed     Text format     Abstract available


  381. LAHMER T, Brandl A, Rasch S, Schmid RM, et al
    Fungal Peritonitis: Underestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis.
    PLoS One. 2016;11:e0158389.
    PubMed     Text format     Abstract available


  382. SI WK, Chung JW, Cho J, Baeg JY, et al
    Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes.
    PLoS One. 2016;11:e0158066.
    PubMed     Text format     Abstract available


  383. GAVITO AL, Bautista D, Suarez J, Badran S, et al
    Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice.
    PLoS One. 2016;11:e0157956.
    PubMed     Text format     Abstract available


  384. ARAUJO-MARIZ C, Lopes EP, Acioli-Santos B, Maruza M, et al
    Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS.
    PLoS One. 2016;11:e0157725.
    PubMed     Text format     Abstract available


  385. JURADO-GARCIA J, Munoz Garcia-Borruel M, Rodriguez-Peralvarez ML, Ruiz-Cuesta P, et al
    Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality.
    PLoS One. 2016;11:e0155822.
    PubMed     Text format     Abstract available


  386. WANG D, Lin H, Xia M, Aleteng Q, et al
    Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study.
    PLoS One. 2016;11:e0157515.
    PubMed     Text format     Abstract available


  387. LEE KF, Tsai YT, Lin CY, Hsieh CB, et al
    Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.
    PLoS One. 2016;11:e0155602.
    PubMed     Text format     Abstract available


  388. XIA MF, Yki-Jarvinen H, Bian H, Lin HD, et al
    Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0160526.
    PubMed     Text format     Abstract available


  389. ZHANG C, Yuan W, Fang J, Wang W, et al
    Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials.
    PLoS One. 2016;11:e0161792.
    PubMed     Text format     Abstract available


  390. GADDAM RR, Fraser R, Badiei A, Chambers S, et al
    Cystathionine-Gamma-Lyase Gene Deletion Protects Mice against Inflammation and Liver Sieve Injury following Polymicrobial Sepsis.
    PLoS One. 2016;11:e0160521.
    PubMed     Text format     Abstract available


  391. GRAUPERA I, Sola E, Fabrellas N, Moreira R, et al
    Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
    PLoS One. 2016;11:e0157371.
    PubMed     Text format     Abstract available


  392. HU S, Zou Z, Li H, Zou G, et al
    The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients.
    PLoS One. 2016;11:e0157486.
    PubMed     Text format     Abstract available


  393. SUZUKI-KEMURIYAMA N, Matsuzaka T, Kuba M, Ohno H, et al
    Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
    PLoS One. 2016;11:e0157580.
    PubMed     Text format     Abstract available


  394. HUNG TH, Lay CJ, Tseng CW, Tsai CC, et al
    The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study.
    PLoS One. 2016;11:e0162987.
    PubMed     Text format     Abstract available


  395. KLEIN S, Hinuber C, Hittatiya K, Schierwagen R, et al
    Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension.
    PLoS One. 2016;11:e0162144.
    PubMed     Text format     Abstract available


  396. HASEGAWA K, Saiura A, Takayama T, Miyagawa S, et al
    Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
    PLoS One. 2016;11:e0162400.
    PubMed     Text format     Abstract available


  397. RACHAKONDA V, Borhani AA, Dunn MA, Andrzejewski M, et al
    Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis.
    PLoS One. 2016;11:e0159142.
    PubMed     Text format     Abstract available


  398. SANSOE G, Aragno M, Mastrocola R, Mengozzi G, et al
    Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data.
    PLoS One. 2016;11:e0162644.
    PubMed     Text format     Abstract available


  399. LIU Y, Zhang S, Zhao Y, Du J, et al
    Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B.
    PLoS One. 2016;11:e0162763.
    PubMed     Text format     Abstract available


  400. CHANG M, Tang H, Liu D, Li Y, et al
    Comparison of Melatonin, Hypertonic Saline, and Hydroxyethyl Starch for Resuscitation of Secondary Intra-Abdominal Hypertension in an Animal Model.
    PLoS One. 2016;11:e0161688.
    PubMed     Text format     Abstract available


  401. PELUSI S, Petta S, Rosso C, Borroni V, et al
    Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0163069.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: